542 related articles for article (PubMed ID: 24415653)
1. What nanomedicine in the clinic right now really forms nanoparticles?
Svenson S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):125-35. PubMed ID: 24415653
[TBL] [Abstract][Full Text] [Related]
2. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry].
Szebeni J
Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188
[TBL] [Abstract][Full Text] [Related]
3. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel: What has been done and the challenges remain ahead.
Bernabeu E; Cagel M; Lagomarsino E; Moretton M; Chiappetta DA
Int J Pharm; 2017 Jun; 526(1-2):474-495. PubMed ID: 28501439
[TBL] [Abstract][Full Text] [Related]
5. Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting.
Gupta M; Agrawal GP; Vyas SP
Curr Mol Med; 2013 Jan; 13(1):179-204. PubMed ID: 22834834
[TBL] [Abstract][Full Text] [Related]
6. Theranostics: are we there yet?
Svenson S
Mol Pharm; 2013 Mar; 10(3):848-56. PubMed ID: 23379301
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
[TBL] [Abstract][Full Text] [Related]
9. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
Muthu MS; Singh S
Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
[TBL] [Abstract][Full Text] [Related]
10. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
12. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
[TBL] [Abstract][Full Text] [Related]
13. Supramolecular Nanomedicine - An Overview.
Sekhon BS
Curr Drug Targets; 2015; 16(13):1407-28. PubMed ID: 25090984
[TBL] [Abstract][Full Text] [Related]
14. Polymeric mixed micelles as nanomedicines: Achievements and perspectives.
Cagel M; Tesan FC; Bernabeu E; Salgueiro MJ; Zubillaga MB; Moretton MA; Chiappetta DA
Eur J Pharm Biopharm; 2017 Apr; 113():211-228. PubMed ID: 28087380
[TBL] [Abstract][Full Text] [Related]
15. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
16. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.
Bala V; Rao S; Boyd BJ; Prestidge CA
J Control Release; 2013 Nov; 172(1):48-61. PubMed ID: 23928356
[TBL] [Abstract][Full Text] [Related]
17. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
Ozeki T; Tagami T
Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
[TBL] [Abstract][Full Text] [Related]
18. Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs.
Kieler-Ferguson HM; Fréchet JM; Szoka FC
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(2):130-8. PubMed ID: 23335566
[TBL] [Abstract][Full Text] [Related]
19. Computational studies of micellar and nanoparticle nanomedicines.
Sen S; Han Y; Rehak P; Vuković L; Král P
Chem Soc Rev; 2018 Jun; 47(11):3849-3860. PubMed ID: 29645040
[TBL] [Abstract][Full Text] [Related]
20. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
